-
We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]
-
Deals & Cases / Piret Jesse, Dr Kaido Künnapas, Lauri Liivat, Piibe Lehtsaar, Triin Ploomipuu, Mirjam Vichmann, Robin Teever, Lise-Lotte Lääne, Liisa Maria Kuuskmaa, Vladislav Leiri, Kadri Puu, Lelde Laviņa, Andris Vilisons
We advised YIT, the largest Finnish urban developer and construction company and also significant in Northern Europe in general, on the establishment of a partnership involving the largest ever residential to-let development project in the Baltic countries, and on local law aspects in all three of the Baltic states regarding the joint venture’s structure. As […]
-
We assisted Synbase, an Estonian service provider for healthcare professionals, on tackling various data protection matters and launching its revolutionary web portal offering access to various evidence-based medicine databases. Supporting healthcare professionals Synbase saves healthcare professionals time by combining the latest knowledge in evidence-based medicine into a convenient, comprehensive service offered now both via an […]
-
We prepared a legal analysis for Antegenes, a provider of novel genetic tests designed to assess personal cancer risks. The analysis explored the possibilities of Antegenes to expand to other countries. Expansion in mind For example, the health startup was facing the question if and on what conditions other European Union member states can limit […]
-
As a part of our Shared Mission program, we advised Antegenes, an Estonian health tech startup on a pro bono basis. Our advice We conducted a legal analysis for Antegenes, an innovative cancer prevention genetic testing provider, which shed light on the company’s ability to offer its services across borders. For example, the question has […]
